Upper Airway Reeducation in Moderate Obstructive Sleep Apnea Syndrome

NCT ID: NCT05911971

Last Updated: 2023-06-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-31

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the effectiveness of a specific reeducation performed by speech therapists in moderate obstructive sleep apnea syndrome, as an alternative to the continuous Positive Anyway Pressure (CPAP) and the mandibular advancement device.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be recruited in the sleep pathology department, following a sleep consultation and/or a polysomnography. They will be randomized between 2 reeducation groups (specific reeducation or sham reeducation) and will have to perform their respective exercises during 3 months. Only one of the 2 reeducations is expected to be effective. To limit performance and measure bias, patients will not be aware of the content of the reeducation in the other group (participants partially blinded of study hypothesis) and therefore these are not described in detail here. The initial clinical assessment will be repeated at 3 and 6 months, by assessors blinded to the reeducation arm, in order to evaluate the short and medium term effectiveness on the the Apnea-Hypopnea Index (AHI) and other outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Moderate Obstructive Sleep Apnea Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Specific reeducation

Specific reeducation

Group Type EXPERIMENTAL

Experimental

Intervention Type OTHER

specific reeducation (not detailed to maintain blinding of participants)

Sham comparator

Sham reeducation

Group Type SHAM_COMPARATOR

Sham comparator

Intervention Type OTHER

sham reeducation (not detailed to maintain blinding of participants)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental

specific reeducation (not detailed to maintain blinding of participants)

Intervention Type OTHER

Sham comparator

sham reeducation (not detailed to maintain blinding of participants)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female, 18 years old minimum
* Diagnosis of moderate OSAS: AHI ≥ 15 events/h and \< 30 events/h at PSG M0
* BMI \< 35 kg/m2

Exclusion Criteria

* MoCA \< 26 (Montreal Cognitive Assessment)
* Craniofacial malformations
* Regular use of hypnotic medications
* Untreated hypothyroidism
* Stroke history
* Cardiac insufficiency
* Severe uncontrolled coronary heart disease
* Severe obstructive nasal disease
* Patients with indication for CPAP in first intention
* Pregnant or breastfeeding woman
* Current participation in another interventional research in OSA
* No affiliation to a social security system or legal beneficiary (except AME,Aide médicale d'état)
* Absence of free, informed, written consent
* Contraindications for TMS: intracranial metallic implant, pacemaker and/or recent or severe cardiac disease, epilepsy, vascular, traumatic, tumor, infectious or metabolic brain lesions, severe alcoholism
* Protected adult under guardianship or curatorship
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Diane PICARD-DUBOIS

Role: PRINCIPAL_INVESTIGATOR

APHP

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service des pathologies du sommeil, Pitié-Salpêtrière hospital

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Diane PICARD-DUBOIS

Role: CONTACT

0142163157

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Diane PICARD-DUBOIS

Role: primary

0142163157

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A02688-33

Identifier Type: OTHER

Identifier Source: secondary_id

APHP210997

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.